Nicole Borsje | Investor Relations, The Blueshirt Group |
Ming Hsieh | Chairman and Chief Executive Officer |
Brandon Perthuis | Chief Commercial Officer |
Lawrence Weiss | Chief Medical Officer |
Paul Kim | Chief Financial Officer |
David Westenberg | Piper Sandler |
Good day and welcome to the Q2 2022 Fulgent Genetics Earnings Conference Call.
As reminder, today's call is being recorded. At this time, I would like to turn the conference over to Nicole Borsje. Please go ahead, ma’am.
Great, thanks.